相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach
Joyce Oloaigbe Ogidigo et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19
Md. Oliullah Rafi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking
Jurica Novak et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
Rameez Jabeer Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
Andrey A. Ivashchenko et al.
CLINICAL INFECTIOUS DISEASES (2021)
Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)
Abbas Khan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
Mubarak A. Alamri et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs
Zhiwei Feng et al.
BRIEFINGS IN BIOINFORMATICS (2021)
A machine learning regression model for the screening and design of potential SARS-CoV-2 protease inhibitors
Gabriela Ilona B. Janairo et al.
NETWORK MODELING AND ANALYSIS IN HEALTH INFORMATICS AND BIOINFORMATICS (2021)
Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm
Akalesh Kumar Verma et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases
Chun-Chi Chen et al.
FEBS JOURNAL (2021)
Can natural products stop the SARS-CoV-2 virus? A docking and molecular dynamics study of a natural product database
Jurica Novak et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
Wei-Chung Chiou et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
Vicky Mody et al.
COMMUNICATIONS BIOLOGY (2021)
Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease
Jian Liu et al.
CHEMICAL PHYSICS (2021)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al.
LANCET (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
Chun-Hui Zhang et al.
ACS CENTRAL SCIENCE (2021)
Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
Madhulata Kumari et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Effectiveness and safety of favipiravir compared to supportive care in moderately to critically ill COVID-19 patients: a retrospective study with propensity score matching sensitivity analysis
Ahmad Alamer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
Impact of COVID-19 on the social, economic, environmental and energy domains: Lessons learnt from a global pandemic
M. Mofijur et al.
SUSTAINABLE PRODUCTION AND CONSUMPTION (2021)
Performance of radial distribution function-based descriptors in the chemoinformatic studies of HIV-1 protease
Jurica Novak et al.
FUTURE MEDICINAL CHEMISTRY (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
Jiabao Xu et al.
VIRUSES-BASEL (2020)
Novel radial distribution function approach in the study of point mutations: the HIV-1 protease case study
Jurica Novak et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
Maria Bzowka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Artificial intelligence and machine learning to fight COVID-19
Ahmad Alimadadi et al.
PHYSIOLOGICAL GENOMICS (2020)
SARS-CoV-2 Main Protease: A Molecular Dynamics Study
Dimas Suarez et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme
Arun Bahadur Gurung et al.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2020)
Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies
Rohit Batra et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases
V. Kumar et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2020)
The socio-economic implications of the coronavirus pandemic (COVID-19): A review
Maria Nicola et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Namrta Choudhry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Irene Maffucci et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2
William R. Martin et al.
JOURNAL OF PROTEOME RESEARCH (2020)
The Influence of Hydrogen Atoms on the Performance of Radial Distribution Function-Based Descriptors in the Chemoinformatic Studies of HIV-1 Protease Complexes with Inhibitors
Jurica Novak et al.
Current Drug Discovery Technologies (2020)
Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation
Teruhisa S. Komatsu et al.
SCIENTIFIC REPORTS (2020)
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
Zeinab Abdelrahman et al.
FRONTIERS IN IMMUNOLOGY (2020)
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
Purushothaman Indu et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2In Vitro
Leike Zhang et al.
VIROLOGICA SINICA (2020)
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
Mohamed Mahdi et al.
VIROLOGY JOURNAL (2020)
Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis
Mahesha Nand et al.
SCIENTIFIC REPORTS (2020)
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
Giovanni Bolcato et al.
SCIENTIFIC REPORTS (2020)
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA
Martiniano Bello et al.
JOURNAL OF MOLECULAR MODELING (2020)
Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking
Sovesh Mohapatra et al.
PLOS ONE (2020)
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
Seri Jo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space
Joel Kowalewski et al.
HELIYON (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Zhiqi Song et al.
VIRUSES-BASEL (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Grid-Based Technologies for In Silico Screening and Drug Design
Vladimir Potemkin et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?
David Ramirez et al.
MOLECULES (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
ChEMBL web services: streamlining access to drug discovery data and utilities
Mark Davies et al.
NUCLEIC ACIDS RESEARCH (2015)
Beware of docking!
Yu-Chian Chen
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Membrane protein folding: how important are hydrogen bonds?
James U. Bowie
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2009)
Technique for Energy Decomposition in the Study of Receptor-Ligand Complexes
Vladimir A. Potemkin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Principles for 3D/4D QSAR classification of drugs
Vladimir Potemkin et al.
DRUG DISCOVERY TODAY (2008)
A new paradigm for pattern recognition of drugs
Vladimir A. Potemkin et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2008)
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Vincent C. C. Cheng et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Modeling of drug molecule orientation within a receptor cavity in the BiS algorithm framework
V. A. Potemkin et al.
JOURNAL OF STRUCTURAL CHEMISTRY (2007)
Tools for integrated sequence-structure analysis with UCSF Chimera
Elaine C. Meng et al.
BMC BIOINFORMATICS (2006)
Only one protomer is active in the dimer of SARS 3C-like proteinase
Hao Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain
JH Shi et al.
FEBS JOURNAL (2006)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)
Mechanism of the maturation process of SARS-CoV 3CL protease
MF Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease
WC Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Severe acute respiratory syndrome coronavirus 3C-like proteinase n terminus is indispensable for proteolytic activity but not for enzyme dimerization - Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations
S Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Severe acute respiratory syndrome (SARS): a review
P Vijayanand et al.
CLINICAL MEDICINE (2004)
Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase
KQ Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Docking and scoring in virtual screening for drug discovery: Methods and applications
DB Kitchen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Multiconformational method for analyzing the biological activity of molecular structures
VA Potemkin et al.
JOURNAL OF STRUCTURAL CHEMISTRY (2002)
A method for multiconformational modeling of the three-dimensional shape of a molecule
EV Bartashevich et al.
JOURNAL OF STRUCTURAL CHEMISTRY (2002)
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain
K Anand et al.
EMBO JOURNAL (2002)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
